nano-bio-electronics

343 Pages·2014·7.74 MB·English

10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image
Guided Therapy
May 12, 13, 14, 2013 Society for Brain Mapping and Therapeuticst - ShBMT
Annual world Congressof 10  
Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare  Policy
SBMT on Brain,
Cord Mapping and
Breaking Boundaries of
Science, Technology, Society for Brain Mapping and Therapeutics - SBMT 
Medicine, Art and
Healthcare Policy 
THEME: NANO-BIO-ELECTRONICS
May 12, 13,
Baltimore Convention Center,
14, 2013
Baltimore, Maryland 

United States of America 

www.worldbrainmapping.org
1
th
10
Annual world Congress

of SBMT on Brain,
Cord Mapping and
Breaking Boundaries of
Science, Technology, Medicine,
Art and Healthcare Policy 
INFO
Society for Brain Mapping and Therapeutics - SBMT
SBMT
Global Headquarters
C
8159 Santa Monica Blvd.,
Suite 200
ontents West Hollywood, CA
90046

Tel: [phone]
Fax: [phone]
SBMT (Mission statement, Educational objectives, [email protected]

Annual world congress, Congress chairs, Charter.)...............p. 3-4 WorldBrainMapping.org

Continuing Medical Education need assessment ...................p.5
CME ACCREDITATION
Continuing Medical Education disclosures.................p.6-8

Society Board of Directors.............p.10-11
Scientific Committee............p.12-15 Accreditation/designation 
Statement:  
SBMT Letter from the Founder............p.16-17
(Babak Kateb) This activity has been planned 
and  implemented  in  accor‐
SBMT President address..................p.18
dance with the Essential Ar‐
(Kuldip Sidhu) eas  and  policies  of  the  Ac‐
creditation  Council  for  Con‐
SBMT Program …....... p.19-21
tinuing  Medical  Education 
Keynote speakers .......... p.22-26 through the joint sponsorship 
of  the  International  Society 
Timetable ............p.27-29
for  Magnetic  Resonace  in 
Sunday May 12 - Scientific program ...........p.30-36 Medicine  (ISMRM)  and  the 
Society for Brain Mapping & 
Monday May 13 - Scientific program .......... p.37-47
Therapeutics  (SBMT).  The 
Tuesday, May 14 - Scientific program …...... p.48-56 ISMRM) is accredited by the 
ACCME to provide continuing 
Oral poster and Posters ......... p. 47-59
medical education for physi‐
Faculty .......... p.59-66 cians. 
Sponsors & Exhibitors .................p.67
The International Society for 
Gala Reception - Awards .......... p.68-70 Magnetic Resonance in Medi‐
cine (ISMRM) designates this 
11th Annual world Congress, Sydney Australia...….……..p. 71
live activity for a maximum of 
9.50  AMA  PRA  Category  1 
Credit(s)™. Physicians should 
claim  only  the  credit  com‐

mensurate with the extent of
10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image
Guided Therapy
May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT

Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy
SBMT Mission Statement

SBMT is a non-profit society organized for the purpose of encouraging basic and clinical scientists
who are interested in areas of Brain Mapping, engineering, stem cell, nanotechnology, imaging
and medical device to improve the diagnosis, treatment and rehabilitation of patients afflicted with
neurological disorders.

This society promotes the public welfare and improves patient care through the translation of new
technologies/therapies into life saving diagnostic and therapeutic procedures. The society is com-
mitted to excellence in education, and scientific discovery. The society achieves its mission
through multi-disciplinary collaborations with government agencies, patient advocacy groups, edu-
cational institutes and industry as well as philanthropic organization.

Educational Objectives
Upon completion of the scientific meeting, participants should be able to:
 Identify new findings in brain mapping (BM) & intraoperative surgical planning (ISP)
most relevant to their own sub field (i.e. molecular imaging and or biophotonics);
 Describe the effect of the newly developed methods in medical imaging, medical
devices, nanotechnology, stem cell/cellular therapy;
 Discuss and design the possible future research and developments in BM, ISP and
Nano-Bio-Electronics and assess the possible impact of such research and devel-
opment on their own clinical and scientific work in the future;
 Describe and assess the latest cutting-edge technological advancement in BM &
ISP such as emerging field of nano-bio-electronics (integration of nanotechnology
with stem cell/cellular therapy, medical imaging and medical devices);
 Explain ways to build a bridge amongst multiple disciplines;
 Educate the audience about the advancements in other disciplines and explain how
such advancements could help them formulate new diagnostics and treatment mo-
dalities;
CONGRESS CHAIRS
 Discuss and describe governmental agencies, founda-
Babak Kateb
tions, and industry roles in research and development of
Michael J. Roy
the field.
Rafat Ansari

Yu Chen
ANNUAL SBMT WORLD CONGRESS
James M. Ecklund
Rao P. Gullapalli
The Annual World Congress is a multi-disciplinary forum designed to James McDonald
facilitate cross-pollination and dissemination of technological and
medical advances and scientific discovery.

The attendees are a mixture of neurosurgeons, radiologists, neurolo-
gists, psychiatrists, rehabilitation medicine, cardiologists, oncologists,
bioethicists, policy makers, government officials, engineers, physicists,
neuroscience, stem cell scientists, Bio-technologists, nano technolo-
3
10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image
Guided Therapy
May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT

Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy
CHARTER of SBMT
The Society for Brain Mapping and Therapeutics (SBMT) was founded in  
2004 to break boundaries in healthcare. The society promotes policies that
support rapid, safe, and cost-effective translation of new technology into
medicine.

The SBMT globally promotes interdisciplinary research to improve the di-
agnosis, treatment, and rehabilitation of patients with central nervous sys-
tem diseases regardless of race, creed, color, national origin, gender, or
age.

The SBMT catalyzes interactions between clinical, biological, physical and
engineering sciences. The Society builds transdisciplinary and translational
consortia which break down traditional barriers that impede application of
new technology to medical problems.

Translational research applies cutting edge basic science and advanced
technologies to clinical neurosciences. The Society examines emerging
disciplines such as nanotechnology, image-guided therapy, stem cell ther-
apy, multi-modality imaging, biophotonics, and biomaterial and tissue engi-
neering for their application to the diagnosis, treatment, and rehabilitation
from neurological diseases. The Society seeks to apply these technologies
to clinical problems such as brain tumors, stroke, epilepsy, neurodegenera-
tive diseases (Parkinson, Alzheimer, multiple sclerosis and ALS), traumatic
brain and spinal cord injuries, autism, post traumatic stress disorder and
other psychiatric illnesses.

The Society achieves its goals through meetings, fellowships, publications,
international collaborations, consortiums, and policy forums. The SBMT is
a nonprofit society which has obtained support from many government
agencies (USA, EU and Asia), foundations, and multi-national corpora-
tions. The Society maintains its headquarters in West Hollywood, Califor-
nia.
4
10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image
Guided Therapy
May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT

Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy
CONTINUING MEDICAL EDUCATION
In recent years astonishing advances have contributed to amazing CHAIR OF THE CME
discoveries and breakthroughs in fields of neurology, neuroscience, COMMITTEE
neurosurgery, radiology, engineering, computer science, nanotech-
nology, medical imaging, medical devices and cellular/stem cell
therapy.

These scientific advances also have contributed to the large gap of
knowledge amongst the scientists in different disciplines. One of the
major challenges of 21st century for the scientific community is how
to close such gaps of knowledge amongst multiple disciplines.
We have designed the annual meeting of SBMT to address such Babak Kateb
challenge by bringing together world class experts across multiple Chairman /CEO SBMT
disciplines. & President of
Brain Mapping
Moreover, we have identified a need for progressive integration of Foundation
nanotechnology, cellular therapy with medical devices and imaging.
This is why we have chosen “Nano-Bio-Electronics” as the theme of
the 10th Annual world Congress of SBMT in Baltimore, Maryland,
USA.

The purpose of the annual meeting is to create an interactive envi-
ronment, which foster cross-pollination of ideas and pave the way
for birth of new treatment and diagnostic modalities in the field..

- - - - - - - - - - - - - - - - - -  

For questions about CME, please contact:

Jacob Coverstone, Director of Education
International Society for Magnetic Resonance in Medicine (ISMRM) &
Section for Magnetic Resonance Technologists (SMRT)
2030 Addison Street, Suite 700
Berkeley, CA 94704 USA

T: [phone] • F: [phone] • E: [email protected]
5
10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image
Guided Therapy
May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT

Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy
CONTINUING MEDICAL EDUCATION (CME)
Disclosure Information: The ISMRM and Society for Brain Mapping and Therapeutics con-
trol the content and production of this CME activity and attempt to ensure the presentation of bal-
anced, objective information. In accordance with the Standards for Commercial Support estab-
lished by the Accreditation Council for Continuing Medical Education (ACCME), faculty, abstract
reviewers, paper presenters/authors, planning committee members, staff and any others involved
in planning the educational content and the significant others of those mentioned must disclose
any relationship they or their co-authors have with commercial interests which may be related to
their content. The ACCME defines "relevant financial relationships" as financial relationships in
any amount occurring within the past 12 months that create a conflict of interest.

Those who have disclosed a relationship* with commercial interests are listed below:
Name Type of Disclosures - What was Disclosed
University Grants/Research Support - NINDS R21NS081416; Pending
Allyson Rosen
VA Merit 1I01CX000604-01, France-Stanford Grant
Andreia Vaconcellos Faria GOVERNMENT FUNDING
University Grants/Research Support Maxine Dunitz Neurosurgical
Christopher J. Wheeler Inst., Cedars-Sinai Medical Center, Dept. of Neurosurgery; Joseph
Drown Foundation Grant
Cynthia Roberts Consultant Fee - Ziemer Ophthalmic Systems AG
University Granst/Research Support: Telemedicinr and Advnaced
Technology Research Center (TATRC)
David F. Tate Consultant Fee: Brigham and Wmoen';s Hospital
Employee: contractor for Henry M. Foundation for the Advancement of
Military Medicine
CONSULTANT -Codman & Shurtleff, Covidian ev3, NFocus Medical,
David Fiorella Cordis, Micrus Endovascular.
Stock/Shareholder: Vascular Simulators LLC
Dawn S. Eliashiv Consultant/Advisor & Lecture fee - UCB and Lundbech
Alcon/Novartis - Consultant/Advisor
Merck - Grant support
Donald J. Zack
Allergan - Consultant/Advisor
Johns Hopkins - Patents/Royalty
University Grants/Research Support - NIH and DOD
E. Mark Haacke
Industry Grant Support - Siemens Medical Solution
Edward Herskovits Grant Support: NIH and Microsoft, Consultant/Advisor: Bioclinca,
* Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for educational services
6
10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image
Guided Therapy
May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT

Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy
CONTINUING MEDICAL EDUCATION (CME)
DISCLOSURE INFORMATION
Name Type of Disclosures - What was Disclosed
Grant Support: Allergan
Ejaz Shamim
Equity/Owner: Medtronic Inc ( own some stock)
Other Financial or Material Support - Royalty payments related to
Elizabeth Hillman
‘DYCE’ dynamic imaging method from MGH / PerkinElmer
Other Financial or Material Support:
Gerard Gioia Psychological Assessment Resources (PASR) Inc. (Patents/Royality),
Impact Application Inc. (test author)
University Grants/Research Support - VA Merit Review Grant Award
J. Wesson Ashford
Consultant Fee Grifols, Inc., Neurotez, Inc.
University Grant/Research Support - NEUROPACE
James Leiphart
Employee - INOVA
University Grant/Research Support: Neuren
James M Ecklund Other Financial Support: President of a consulting company for gov-
ernment and military relevant neurotrauma
James Pekar Industry Grant Support: Phillips HealthCare, Inc.
Other Financial or Material Support - None financially but I am co-
James Welsh
founder of Radion Global, a board member of Coqui
Jane Tavyev Asher Research Support: Muscular Dystrophy Association
Other Financial or Material Support - J.P.C and Washington University
Joseph Culver have financial interests in Cephalogics LLC based on a license of re-
lated optical imaging technology by the University to Cephalogics LLC.
Joshua Medow BHR Pharma Project Trial Grant.
Lee Martin Grant Support: Congenia
Leonard A. Levin Consultant and Employee: Medtronic Inc.
Maria Angela Franceschini University Grants/Research Support Canon USA, ISS Inc
Stock or Shareholder - Founding member and Shareholder in NeuroVi-
Maya Koronyo-Hamaoui sion Imaging LLC (NVI)
Speaker’s Bureau - NVI
Michael Wright Employee: Varian Medical Systems, Inc
Mohan Vemuri Owns stock from the company (Life Tech)
* Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for educational services
elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure. 
7
10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image
Guided Therapy
May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT

Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy
CONTINUING MEDICAL EDUCATION (CME)
DISCLOSURE INFORMATION

Name Type of Disclosures - What was Disclosed
Consultant, Neuroelectrics Barcelona. This company produces toes
Pedro Cavaleiro Miranda
devices.
Peter van Zijl Industry Grant Support: Philips Healthcare
Stock or Shareholder - to-BBB holding BV (founder shares and stock
Pieter Gaillard options)
Employee [any industry] - to-BBB technologies BV (salary)
Roger Little Stock or Shareholder - AstraZeneca (spouse)
Stock or Shareholder and Employee:
Rohan Fernandes
Spouse Varnika Roy, Scientist I - MedImmune, LLC
University Grant/Research Support: NIH, Am. Heart Assn., Research
Ruikang K Wang for Prevention of Blindness
Consultant Fee: Vistaon J&J Vison Prod. Inc
Shattnath Merbs Consultant Fee: Spouse with Stryker
University Grants/Research Support - Spouse: Research grants/
contracts through Johns Hopkins University
Industry Grant Support - Spouse: Amgen, Avid Pharmaceuticals/Eli
Susan Resnick Lilly, Biotie, Intracellular, Johnson and Johnson, Lundbeck, Roche
Consultant Fee - Spouse: Consultant/Honoraria from Amgen
Stock or Shareholder
Honorarium - Spouse: Consultant/Honoraria from Amgen
Industry Grant Support: Stryker, Audax,
Consultant Fee: Nanovis
Thomas Webster
Stock or Shareholder: Nanovis, Audax
Honorarium: International Journal of Nanomedicine
Xingde Li Other Financial Support: Rotality payment from LightLab Imaging LLC
Zachary T. Levine Consultant/Advisor and Employee: Medtronic Inc.
Consultant/Advisor: Medtronic, IPSEN, MERZ, US World Meds
Zoltan Mari
Grant Support: Allergin, ABBOTT
* Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for educational services
elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure. 
8
10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image
Guided Therapy
May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT

Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy
CONTINUING MEDICAL EDUCATION (CME)
DISCLOSURE INFORMATION

Alberto Bravin Jaydev Desai Nilesh Vyas
Alexander Potapov Jean Paul Allain Panayiotis Sioutos
Andrei Medvedev Jeff Elias Pantaleo Romanelli
Andrew Degnan Jeff Teigler Paola Coan
Andrew Dunn Jeffrey Chung Patricia Raksin
Anindo Roy Jennifer L. Hopp Paul Pasquina
Babak Kateb Jennifer Rusiecki Paul Patterson
Beverly C. Walters Jim Smirniotopoulos Philip A. Defina
Bizhan Aarabi John W. McDonald Pranav Vyas
Carlos Pardo Jorge M. Serrador QingmingLuo
Carol A. Miller Josep A. Planell Rasul Chaudhry
Carson Smith Juan Jose Pavon Palacio Robert Lipsky
Chandler Sours Juan Troncoso Robert Stern
Codrin Ion Lungu Julie Chapman Robert W. Nickells
Congwu Du Kaisorn L. Chaichana Roger Packer
Craig Atwood Kareem A. Zaghloul Roger Packer
Daniel C. Lee Katherine Warren Ronald Goodman
Daniel E. Callan Keith Main Russel Lonser
David Seminowicz Kenichi Oishi Shailesh Kantak
Dongju Seo Kevin Crutchfield Shuo Chen
Elaine Shen Kewal Jain Song Hu
Eliot Siegel Kuldip Sidhu Stewart H. Mostofsky
Elisabeth Schultke Laith Altaweel Sujit Prabhu
Evgeny Tsimerinov Larry Forrester Susan Conroy
Geoff Ling Ling Li Tao Lu Lowe
Gilbert Vezina Lori Beason-Held Thom A. Mayer
Graeme Woodworth Madhav Thambisetty Vassiliy Tsytsarev
Guoying Liu Maheen Mausoof Adamson Vicky Yamamoto
H. Ronald Zielke Manuel B. Datiles Visar Belegu
Hanli Liu Martina Stippler Vivek Patel
Hillard Lazarus Meenakshi Malhotra Waguih W. IsHak
Jamie Grimes Michael J. Roy Xuemei Wang
* Relationship refers to receipt of royalties, consultantship, funding by research grant, receiving honoraria for educational services
elsewhere, or any other relationship to a commercial interest that provides sufficient reason for disclosure.

9
10th Annual World Congress of SBMT on Brain, Spinal Cord Mapping and Image
Guided Therapy
May 12, 13, 14, 2013 Society for Brain Mapping and Therapeutics - SBMT

Breaking Boundaries of Science, Technology, Medicine, Art and Healthcare Policy
SOCIETY BOARD OF DIRECTORS

Kuldip Sidhu
Babak Kateb, Michael J. Roy,
Vice President,
Chairman/CEO SBMT 9th President,
SBMT
& President of Brain SBMT
Associate Professor, Stem Cell
Director of Internal Medicine,
Mapping Foundation USUHS, Arlington, Virginia Research, University of New
      South Wales

Michele R. Aizenberg
Assistant Professor,
Mitchel S. Berger
Brain and Spine Can- Rafat Ansari
Professor and Chair, Depart-
cer Center University of Human Research Program ment of Neurological Surgery,
NASA/ GRC
Nebraska Medical Cen- UCSF

ter

Benjamin Oliver Burt, Michael Y. Chen, Kirsty Duncan
  Assistant professor of Oculoplastic   Associate Professor of De-   Member of Canadian Parlia-
and Orbitofacial Surgery, Texas partment of Neurosurgery, ment;
Tech University City of Hope Cancer Center Etobicoke, Canada

Massimo S. Fian-
daca
Michael Fehlings Warren Grundfest
Associate Professor, Re-

Professor, Department of Surgery, search Track, Professor of Surgery, UCLA
University of Toronto Department of Neurology Geffen School of Medicine
Georgetown University Medi-
cal Center

Lucien Levy
Kian Kaviani Professor of Radiology and Robert Nickells
Director Neuroradiology
Professor of Electrical Engineering, Vice Chairman of Research,
    Senior Editor, American
Ming Hsieh Electrical Engineering UW Comprehensive Cancer
Journal of Neuroradiology
Dept., Viterbi School of Engineer- Center, Institute on Aging and
George Washington Univer-
ing the Eye Research Institute
sity Medical Center, Wash-

ington, D.C.
10